The treatment of cutaneous immune-related adverse events from immune checkpoint inhibitors with biologic therapy: A single-institution retrospective study at a tertiary care cancer center.
作者信息
Greenberg Ana B W, Valido Kailyn, Vesely Matthew, Leventhal Jonathan S
机构信息
Yale School of Medicine, New Haven, Connecticut.
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
出版信息
J Am Acad Dermatol. 2025 Sep;93(3):797-799. doi: 10.1016/j.jaad.2025.04.075. Epub 2025 May 7.
Abstract
摘要
相似文献
1
The treatment of cutaneous immune-related adverse events from immune checkpoint inhibitors with biologic therapy: A single-institution retrospective study at a tertiary care cancer center.生物疗法治疗免疫检查点抑制剂引起的皮肤免疫相关不良事件：一家三级护理癌症中心的单机构回顾性研究
J Am Acad Dermatol. 2025 Sep;93(3):797-799. doi: 10.1016/j.jaad.2025.04.075. Epub 2025 May 7.
2
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.免疫检查点抑制剂引起的多器官免疫相关不良事件及其下游影响：一项回顾性多队列研究。
Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study.癌症类型和组织学影响皮肤免疫治疗的毒性：一项多机构队列研究。
Br J Dermatol. 2024 Jun 20;191(1):117-124. doi: 10.1093/bjd/ljae053.
5
Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy-a single center experience.迟发性中度毒性是个好兆头：检查点抑制剂免疫治疗中毒性与生存的关联——单中心经验
Front Immunol. 2025 Apr 28;16:1527103. doi: 10.3389/fimmu.2025.1527103. eCollection 2025.
6
Immunotherapy for advanced or metastatic urothelial carcinoma.晚期或转移性尿路上皮癌的免疫治疗。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013774. doi: 10.1002/14651858.CD013774.pub2.
7
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study.生物制剂用于治疗免疫检查点抑制剂继发的皮肤免疫相关不良事件：一项单机构真实世界研究。
JAAD Case Rep. 2023 Nov 2;43:1-3. doi: 10.1016/j.jdcr.2023.09.041. eCollection 2024 Jan.
8
Impact of comorbidity on immune-related adverse events and survival in older cancer patients treated with immunotherapy.合并症对接受免疫治疗的老年癌症患者免疫相关不良事件和生存的影响。
Future Oncol. 2025 Jun;21(14):1787-1796. doi: 10.1080/14796694.2025.2502313. Epub 2025 May 27.
9
Survival impact of immune-related adverse events in extensive stage small cell lung cancer patients: a retrospective cohort study.广泛期小细胞肺癌患者免疫相关不良事件的生存影响：一项回顾性队列研究
Immunotherapy. 2025 Jan;17(1):19-24. doi: 10.1080/1750743X.2025.2456448. Epub 2025 Jan 23.
10
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience.免疫相关不良事件和免疫检查点抑制剂再挑战中的耐受：单中心经验。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2789-2800. doi: 10.1007/s00432-021-03610-w. Epub 2021 Mar 28.
本文引用的文献
1
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases.生物制剂在治疗免疫检查点抑制剂相关皮肤免疫相关不良事件中的应用：病例报告综述。
Am J Clin Dermatol. 2024 Jul;25(4):595-607. doi: 10.1007/s40257-024-00866-z. Epub 2024 May 20.
2
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study.生物制剂用于治疗免疫检查点抑制剂继发的皮肤免疫相关不良事件：一项单机构真实世界研究。
JAAD Case Rep. 2023 Nov 2;43:1-3. doi: 10.1016/j.jdcr.2023.09.041. eCollection 2024 Jan.
3
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid.生物疗法对免疫检查点抑制剂诱导的大疱性类天疱疮患者癌症预后的影响。
J Am Acad Dermatol. 2023 Mar;88(3):670-671. doi: 10.1016/j.jaad.2022.06.1186. Epub 2022 Jun 30.
4
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.免疫检查点抑制剂治疗相关炎症性皮疹：毒性分层的单机构回顾性分析及其对治疗的影响。
J Am Acad Dermatol. 2019 Apr;80(4):990-997. doi: 10.1016/j.jaad.2018.10.062. Epub 2018 Nov 3.
5
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.基线类固醇对非小细胞肺癌患者程序性细胞死亡-1 和程序性死亡配体 1 阻断疗效的影响。
J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.
Zotero 插件